The Future of Metabolic Health, Liver Disease and related NCDs

As the global health architecture advances towards greater integration to build more resilient health systems, the inclusion of liver health within metabolic, noncommunicable disease and universal healthcare frameworks is becoming increasingly important for the well-being of the global population.

Shared risk factors and emerging treatment options are reinforcing the links between metabolic conditions, creating opportunities to develop strategies that coordinate prevention, timely detection, and management measures among these conditions. Health systems must be prepared to quickly adapt, promote multidisciplinary collaboration, and to recognise that metabolic health must be at the forefront of universal health coverage (UHC).

What do future-ready health systems mean for metabolic health?

This scenario-setting session will explore how care for metabolic health, and in particular steatotic liver disease, should evolve in 3, 5 and 10 years. We will examine the patient pathway from diagnosis and linkage to care, to treatment, and consider how health systems can adapt to address interconnected metabolic conditions in a more coordinated way within UHC frameworks.

Major themes will include how health systems can facilitate earlier and more scalable diagnosis, how digitally enabled and patient-centred self-care can support prevention and management, and how emerging treatments can reshape care pathways, potentially limiting the need for engagement with hospitals, healthcare professionals and pharmacies. Join us as we consider how future health systems could transform liver care while strengthening metabolic health and progress towards UHC.